| 000 | 01758 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512204820.0 | ||
| 264 | 0 | _c19820807 | |
| 008 | 198208s 0 0 eng d | ||
| 022 | _a0361-5960 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChahinian, A P | |
| 245 | 0 | 0 |
_aChemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer. _h[electronic resource] |
| 260 |
_bCancer treatment reports _cJun 1982 |
||
| 300 |
_a1291-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xtherapy |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aBacterial Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xtherapy |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xtherapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevamisole _xadministration & dosage |
| 650 | 0 | 4 |
_aLomustine _xadministration & dosage |
| 650 | 0 | 4 |
_aLung Neoplasms _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPropionibacterium acnes _ximmunology |
| 650 | 0 | 4 | _aRandom Allocation |
| 700 | 1 | _aGoldberg, J | |
| 700 | 1 | _aHolland, J F | |
| 700 | 1 | _aReisman, A | |
| 700 | 1 | _aJaffrey, I S | |
| 700 | 1 | _aMandel, E M | |
| 773 | 0 |
_tCancer treatment reports _gvol. 66 _gno. 6 _gp. 1291-7 |
|
| 999 |
_c6282382 _d6282382 |
||